Bayer has announced plans to shut down its herbicide production and development operations at the Frankfurt am Main site by the end of 2028, marking the first closure of a German factory in the ...

Bayer’s strong first quarter performance was mainly driven by its pharmaceuticals division, even as its crop-science branch lagged. German pharmaceutical giant Bayer’s shares jumped 10.5% on ...

German agrochemical company Bayer — last week holding its annual shareholders meeting (AGM) – should not be seeking legal impunity.Nor should any other corporation. In an o pen letter to Bayer's ...

German pharmaceuticals and agrichemicals firm Bayer said Friday it could be forced to pull its Roundup weedkiller from the market if it is not able to contain simmering legal troubles.

Bayer is expanding its Lebanon County facility by adding 70,000 square feet of production space and incorporating new automated technologies. Skip to content. NOWCAST WGAL News 8 at 11:00.

German agricultural and pharmaceutical giant Bayer has been instructed by a state court in the US state of Georgia to shell out $2.1 billion (€1.9bn) in a case regarding its Roundup weed killer ...

Bayer joined the cast of “Saturday Night Live” as a featured player in 2010. NBCU Photo Bank/NBCUniversal via Getty Images. Bayer grew impatient amid two weeks of waiting for NBC to reveal ...

In a bold move to restore $540 million in cost savings, Bayer CEO Bill Anderson cut out most of the company’s management roles last year. Since taking the helm in 2023, Anderson’s maneuvers ...

Faced with huge debt, the impending expiry of a crucial patent, and ongoing litigation over a horror acquisition, Bayer CEO Bill Anderson made a bold move a year ago to get his damaged company ...

Bayer must pay $78 million to a Pennsylvania man who said he got cancer from using the company's Roundup weedkiller, a state court jury in Philadelphia found on Thursday.

Bayer (BAYRY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

The biotech giant Bayer has lobbied Congress over the past year to advance legislation that could shield the company from billions of dollars in lawsuits, part of a national campaign to defeat ...